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Abstract
Background—An issue of critical importance for psychiatry and women’s health is whether 
postpartum depression (PPD) represents a unique condition. The Diagnostic and Statistical 
Manual of Mental Disorders asserts that major depressive disorder (MDD) may present with 
peripartum onset, without suggesting any other differences between MDD and PPD. The absence 
of any distinct features calls into question the nosologic validity of PPD as a diagnostic category. 
The present study investigates whether symptom profiles differ between PPD and depression 
occurring outside the postpartum phase.
Methods—In a prospective, longitudinal study of parturient women (N=239), we examine the 
manifestation of depression symptoms. We assess factor structure of symptom profiles, and 
whether factors are differentially pronounced during and after the postpartum period.
Results—Factors were revealed representing: Worry, Emotional/Circadian/Energetic 
Dysregulation, Somatic/Cognitive, Appetite, Distress Display, and Anger symptoms. The factor 
structure was validated at postpartum and after-postpartum timepoints. Interestingly, the Worry 
factor, comprising anxiety and guilt, was significantly more pronounced during the postpartum 
timepoint, and the Emotional/Circadian/Energetic Dysregulation factor, which contained sadness 
and anhedonia, was significantly less pronounced during the postpartum period.
Conclusions—These results suggest that PPD may be a unique syndrome, necessitating 
research, diagnosis, and treatment strategies distinct from those for MDD. Results indicate the 
possibility that worry is an enhanced feature of PPD compared to depression outside the 
postpartum period, and the crucial role of sadness/anhedonia in MDD diagnosis may be less 
applicable to PPD diagnosis.
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1. INTRODUCTION
Depression conveys the greatest burden of any disease in the U.S. (C. J. Murray et al., 2013), 
and represents a unique public heath challenge due to the combined effects of its ubiquity, 
heterogeneity, bio-socio-psychological complexity, and the suffering it imposes on 
individuals, families, and communities. One of the most frequent yet understudied 
precipitators of depression is childbearing. It has been estimated that globally, 1 in 8 new 
mothers suffers from postpartum depression (PPD) (O’Hara & Swain, 1996). PPD inflicts an 
exceptionally pernicious impact because it poses serious threats to the well-being of both the 
mother (Goodman, 2007; O’Hara, 2009) and child. Infants of mothers suffering from PPD 
exhibit higher mortality rates and lifelong cognitive, social, and health detriments 
(Goodman, 2007; L. Murray et al., 2011; Verbeek et al., 2012).
Despite the high incidence and personally damaging repercussions of PPD, it is not known 
whether PPD represents a distinct syndrome from major depressive disorder (MDD) 
occurring outside the peripartum period (Bernstein et al., 2008; Hendrick, Altshuler, Strouse, 
& Grosser, 2000). As a result, we are severely limited in our ability to recognize or intervene 
in this devastating mental illness. Here, we address this major lacuna in our understanding of 
depression during the peripartum phase. Our approach focuses on symptom clustering and 
differential manifestation of particular symptom constellations in response to childbearing to 
determine the validity of PPD as a diagnostic category.
Whether PPD is different from MDD is a question of scientific and clinical relevance. In 
order to resolve its diagnostic status, it must be determined whether PPD has 
psychobiological mechanisms of risk, etiology, or manifestation that are unique from those 
of MDD. It is plausible to expect that PPD etiology is distinct from etiology of depression 
occurring outside the perinatal phase because endocrine regulation of mood has been 
implicated in a wide range of psychopathologies (Taylor, Maloney, Dearborn, & Weiss, 
2009) and pregnancy involves endocrine fluctuations that are unparalleled in magnitude 
compared to the rest of the lifespan, even puberty and menopause (Tulchinsky & Little, 
1994). Strong evidence from animal models and emerging evidence from human research 
suggests that pregnancy induces profound alterations to maternal brain structure and 
function (Glynn, 2010; Glynn, Davis, Sandman, & Goldberg, 2016; Yim et al., 2009). The 
distinctive endocrine experience and exceptional neuroplasticity associated with pregnancy 
justify the hypothesis that PPD may have distinct etiologic characteristics compared to 
depression occurring during other life phases.
Furthermore, PPD and MDD are associated with different neurobiological profiles. Women 
with PPD exhibit hypoactive resting-state neural activity in cortical and subcortical limbic 
regions compared with non-PPD mothers, while non-perinatal MDD men and women 
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exhibit hypoactive resting-state neural activity in lateral brain regions and resting-state 
hyperactivity in medial affective and subcortical limbic regions compared with non-MDD 
individuals (reviewed in (Pawluski, Lonstein, & Fleming, 2017)). PPD and MDD are also 
associated with divergent activation profiles in response to non-infant emotional cues. 
Women with PPD exhibit lower activation in the amygdala and striatum (Barrett et al., 2012; 
Moses-Kolko, Horner, Phillips, Hipwell, & Swain, 2014), and individuals with MDD exhibit 
higher activation in the amygdala and striatum (Drevets, 2000; Phillips, Drevets, Rauch, & 
Lane, 2003). These differences in brain resting-state and activation profiles suggest that PPD 
could be a condition etiologically distinct from MDD, or have distinct characteristics.
The National Institutes of Mental Health (NIMH) recently instituted the Research Domain 
Criteria (RDoC) project in response to the limitations traditional diagnostic categories 
impose on the study of mental illness (Cuthbert & Insel, 2013). Our study design is 
compatible with the RDoC emphases on dimensionality and deconstruction of 
heterogeneous diagnostic categories (e.g., MDD) into fundamental components. In terms of 
dimensionality, we utilize a continuous scale measurement of each depressive symptom 
rather than the traditional binary medical approach, i.e., “depressed” versus “not depressed.” 
Exploring the essence and constitution of PPD requires a gradient quantitative analysis as a 
precondition of developing binary systems of participant recruitment and statistical analysis. 
In terms of deconstructing heterogeneous diagnostic categories into fundamental 
components, we assert that symptom-based approaches are necessary for clarifying how we 
define and classify mental illnesses (Calamari, Wiegartz, & Janeck, 1999) in order to 
identify biomarkers and genetic risk factors, and evaluate treatment efficacy (Bech, 2006; 
Fried & Nesse, 2015). For depression research, this necessity is born out in evidence that 
specific symptoms, compared with threshold scores, have demonstrated stronger 
relationships with allelic variants (Kendler, Aggen, & Neale, 2013; Myung et al., 2012), 
inflammatory (Duivis, Vogelzangs, Kupper, de Jonge, & Penninx, 2013) and hormone 
profiles (Lamers et al., 2013), and antidepressant responses (Dew et al., 1997). Subtyping of 
depression has been based upon symptom profiles (e.g., atypical), precipitating causes (e.g., 
seasonal affective disorder), or both (Keller & Nesse, 2006). This study will inform our 
understanding of whether the precipitating event of childbirth justifies a depression subtype 
or distinct syndrome based on symptom profiles, beyond just a precipitating event specifier 
(viz. Diagnostic and Statistical Manual of Mental Disorders (DSM)-5). While the PPD 
acronym may refer to either perinatal or postpartum depression, here we utilize the latter 
terminology because our timepoint of interest is during the postpartum phase.
Despite the necessity and benefits of symptom-based approaches for diagnosing and 
studying depression, many studies use categories based on depression rating scale sum score 
cutoffs, which amalgamate individuals into one undifferentiated classification. This 
procedure is based on the erroneous suppositions that depression is a monolithic syndrome, 
and all symptoms are interchangeable and contribute equivalently to diagnostic classification 
(Fried & Nesse, 2015). Psychometrically validated instruments that are used to assess 
depression in clinical research utilize the sum of self-reported Likert-scale assessments, with 
a threshold cutoff score for classifying individuals as depressed. The use of sum scores and 
cutoff thresholds imposes three major impediments to research. Firstly, a sum score reveals 
no information about symptomology, and this loss of information impairs the interpretability 
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of the score. Secondly, cutoff thresholds treat all symptoms as having equivalent importance 
for diagnosis. This practice is contrary to the diagnostic criteria of the DSM and 
International Statistical Classification of Diseases (ICD), which highlight certain symptoms 
as necessary and others as ancillary (Table 2). Myriad combinations of symptom 
endorsements and severities can result in scores above the threshold. Thirdly, cutoff 
thresholds result in loss of the dimensionality that is valuable for statistically modeling 
depression’s relationships with risk factors and consequences.
We posit the widely-held assumption of PPD’s symptomatic similitude with MDD along 
with the wide use of sum score cutoffs to study PPD may have obfuscated unique aspects of 
perinatal mood dysregulation that could prove crucial for discerning the etiology of this 
ubiquitous form of mental illness. We therefore aim to discern whether depressive symptom 
constellations manifest differently during the postpartum phase compared with years later. 
We use a dimensional approach by measuring symptomology in the full cohort, and also 
repeat all analyses for the subset of women who meet traditional research study criteria for 
at least minor depression (Martens et al., 2006; S Matthey, Henshaw, Elliott, & Barnett, 
2006), for the subset of women who did not use anti-depressant medications at the 
postpartum timepoint, and for the subsets of women who were and were not breastfeeding at 
the postpartum timepoint.
2. METHODS
2.1. Cohort and procedure
Study participants were 239 women participating in a longitudinal study on mother-child 
psychobiology and development at a university in California. Women were enrolled during 
early pregnancy if they met eligibility criteria of singleton pregnancy, English-speaking, 
non-smoking, age 18+, without use of steroid medications, drug or alcohol use during 
pregnancy. The study was conducted in compliance with the Code of Ethics of the World 
Medical Association and the Declaration of Helsinki. The protocol was approved by the 
institutional review boards of participating universities. All participants provided written, 
informed consent after receiving a complete description of study procedures.
To compare depression during postpartum and non-peripartum life-phases, we identified two 
timepoints in our protocol from which to draw data. We determined the timing of the 
postpartum phase by taking into consideration the inconsistent literature on this subject 
(Wisner, Moses-Kolko, & Sit, 2010), which has defined postpartum as spanning from 
parturition through 1-month (American_Psychiatric_Association, 1994), 1.5-months 
(World_Health_Organization, 2016), 6-months (Miller, 2002; Viguera et al., 2011) and 12-
months afterwards (Munk-Olsen, Laursen, Pedersen, Mors, & Mortensen, 2006). PPD onset 
can occur at any time across several months after parturition (Stowe, Hostetter, & Newport, 
2005), with peak phase of vulnerability at 3-months (Elliott, 2000; Munk-Olsen et al., 2006). 
Accordingly, we selected the assessment occurring 3-months after parturition to represent 
the “postpartum” timepoint, and the assessment occurring 24-months after parturition to 
represent the “after-postpartum” timepoint. Analyses herein compare depression symptom 
profiles assessed at these two timepoints. Participants were excluded if they had another 
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pregnancy during the 24-month follow-up period (N=36). Details about the cohort are 
presented in Table 1.
2.2. Symptoms of depression
Our first step towards investigating the symptom profiles of PPD was compiling a 
comprehensive list of 53 depression symptoms based on authoritative sources (Table 2). 
Because the larger, longitudinal study of mother-child psychobiology was not designed with 
the present approach in mind, not all depression symptoms had a corresponding item. From 
the full list of possible symptoms, we found corresponding items by searching through the 
instruments administered in our longitudinal study, selecting items that were administered at 
both the postpartum and after-postpartum timepoints. The selection of items was discussed 
and refined by a group of clinical and academic researchers representing several academic 
disciplines, including Psychology, Psychiatry, and Biological Anthropology. Ultimately, 
selected items were agreed to reflect 21 symptoms of depression (Table 2).
2.3. Statistical methods
Data were unitized so each symptom scaled 0–1, where 0 is the lowest and 1 is the highest 
possible score even if those ends of the scale were not endorsed. The full cohort at the 
postpartum timepoint was randomly split into two subsets, Cohort-Half-1 and Cohort-
Half-2, in order to perform exploratory factor analysis (EFA) on one half and confirmatory 
factory analysis (CFA) on the other half as a cross-validation of the determined factor 
structure. The groups did not significantly differ on socio-demographic or health-related 
traits, with the exception of number of obstetric risk factors (Table 1).
EFA was conducted on Cohort-Half-1 to assess whether particular symptoms segregate 
together to produce clusters in depression symptomology during the postpartum period. EFA 
was performed using psych, nFactors, and GPArotation packages for R. Kaiser’s eigenvalue 
criterion (Kaiser, 1960), parallel analysis (Horn, 1965), and Raiche’s optimal coordinates 
approach (Raîche, Walls, Magis, Riopel, & Blais, 2013) all suggested extracting 6 factors 
(Supporting Information Figure S1). The average residuals for the correlation matrix (root 
mean square of residuals) of the 6-factor model was 0.04, indicating excellent fit. These 
criteria converged to support the retention of 6 factors from the dataset.
Maximum Likelihood (ML) estimation was selected for factor extraction, because it 
estimates the level of shared variance for each item, and it has been shown experimentally to 
produce more generalizable and reproducible results than other methods (Osborne & 
Costello, 2009). The retained factors were rotated obliquely using a minimizing criterion.
Confirmatory factor analysis (CFA) was conducted to assess the stability of the factor 
structure suggested by EFA in three analyses. (1) CFA assessed the factor structure stability 
at the postpartum timepoint in Cohort-Half-1 and Cohort-Half-2. (2) CFA assessed the fit of 
the determined factor structure using the same cohort’s responses to the same items at the 
after-postpartum timepoint. (3) CFA was conducted on the subset of women (N=86) who 
met traditional research study criteria for at least minor depression at the postpartum 
timepoint (Table 1) (Irwin, Artin, & Oxman, 1999), and on the subset of women (N=229) 
who did not use anti-depressant medications at the postpartum timepoint (Table S3). 
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Insufficient sample size prevented us from conducting separate analyses on the subset of 
women who met traditional criteria for major depression (N=20). For CFA analyses, we 
used the lavaan package for R, and assessed whether Heywood cases were detected based on 
error variances and squared multiple correlations (SMCs) for each item. We inspected 
standardized residual correlation tables, modification indices, and fit indices.
We assessed whether the prevalences of symptom clusters differ meaningfully between the 
postpartum and after-postpartum timepoints by measurement invariance modelling (using 
the semTools package for R) and paired t-tests. For paired t-tests, in order to avoid any 
influence from attrition in participation, after confirming the likelihood that data were 
missing at random within identifiable strata (Heitjan & Basu, 1996), we used multivariate 
imputation by chained equations (Azur, Stuart, Frangakis, & Leaf, 2011; Buuren & 
Groothuis-Oudshoorn, 2011), utilizing women’s demographic characteristics, obstetric 
history, marital and cohabitation status with the baby’s father, and depressive symptoms 
measured at 6-months and 12-months postpartum to impute missing symptom scores at 24-
months postpartum (N=112) using predictive mean matching (PMM). PMM assures imputed 
values are plausible, and is robust for non-normally distributed data (Horton & Lipsitz, 
2001). We followed standard procedure in which missing values are replaced with 
predictions derived from regression models over 10 cycles (Raghunathan, Solenberger, & 
Van Hoewyk, 2002), repeating this entire process 5 times (Graham, Olchowski, & Gilreath, 
2007). T-test results were pooled (Harel & Zhou, 2007).
To validate the results obtained with the above procedures, we also employed a secondary 
methodology. Linear mixed effects models were fit by restricted maximum likelihood 
estimation (Verbeke & Molenberghs, 2009) with random intercepts for individual identity to 
assess the relation between symptom factor scores and timepoints. To describe results, we 
report pooled Pearson product-moment correlations between scores at the postpartum and 
after-postpartum timepoints for the factors. Analyses of imputed data utilize R packages 
Amelia, mice, and miceadds.
3. RESULTS
Results of the EFA indicated face validity of the resulting factor structure, with symptom 
clusters that had clinical meaning (Table 3). Factor 1 reflected a “Worry” cluster, consisting 
of anxiety and guilt. Factor 2 reflected an “Anger” symptom cluster. Factor 3 contained 
several items such as anhedonia, inability to stay asleep, and fatigue, and was deemed 
“Emotional/Circadian/Energetic Dysregulation.” Factor 4 reflected “Appetite.” Factor 5 
included “Somatic/Cognitive” items. Factor 6 consisted of items that reflect the behavioral 
expression of negative affectivity, so we deem it “Distress display.”
Results of the EFA were highly parsimonious, with only one symptom loading at the 0.3 
threshold onto more than one factor (Table 3). “Anger” loaded at 0.46 onto Factor 2 and .30 
onto Factor 3, so the Factor with the higher loading was selected for this item. Because of 
the simple structure of our results, only the loading of each item on its respective factor are 
displayed. “Pessimism” and “Negative reactivity” had no loadings above 0.30, so were not 
included in the factor structure.
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Results suggested no differences in symptom segregation profiles between the two random 
halves of the cohort at the postpartum timepoint. CFA supported the 6-factor model derived 
from the EFA as a good fit for the data in both Cohort-Half-1 and Cohort-Half-2. All fit 
indices indicated superior fit for the 6-factor compared with the null (one-factor) model 
(Table 4) and SMCs were higher in the 6-factor compared with the null model (M=0.2 
higher for Cohort-Half-1, M=0.1 higher for Cohort-Half-2, Supporting Information Table 
S1).
Results suggested no differences in how symptoms segregate between the postpartum and 
after-postpartum timepoints. We claim the same factor structure holds across timepoints 
based on achievement of configural, metric, and scalar invariance (Meredith, 1993; 
Vandenberg & Lance, 2000). For configural invariance, CFA supported the 6-factor model 
derived from the EFA as a good fit for the data at the after-postpartum timepoint. All fit 
indices indicated superior fit for the 6-factor compared with the null model (Table 4) and 
SMCs were higher in the 6-factor compared with the null model (M=0.1 higher, Supporting 
Information Table S1). Configural invariance indicates that the same pattern of relationships 
between indicators and latent variables holds across timepoints. Metric invariance suggests 
that in addition to latent variables measured by the same indicators, factor loadings are 
equivalent across administrations. For metric invariance (Supporting Information Table S4), 
chi-square change between the configural and metric models is nonsignificant (p=0.12) 
indicating that factor loadings are invariant across timepoints. For scalar invariance 
(Supporting Information Table S4), chi-square change between the metric and scalar models 
is nonsignificant (p=0.36) indicating that item intercepts are equivalent across timepoints. 
Configural, metric, and scalar invariance justify comparison of factor means across 
timepoints. The model did not exhibit strict invariance (chi-square p<0.00, Supporting 
Information Table S4), indicating variance in residual variances across timepoints, but strict 
invariance is highly constrained and rarely achieved in practice (Bialosiewicz, Murphy, & 
Berry, 2013; Millsap & Meredith, 2007).
The same symptom profile structure also robustly applied to the subset of data from women 
who met traditional depression criteria at the postpartum timepoint (Table 1). CFA supported 
the 6-factor model derived from EFA as a good fit for the data for women above the 
traditional cutoff thresholds for at least minor depression at the postpartum timepoint. All fit 
indices indicated superior fit for the 6-factor compared with the null model (Table 4) and 
SMCs were higher in the 6-factor compared with the null model (M=0.1 higher, Supporting 
Information Table S1). The same symptom profile structure also robustly applied to the 
subsets of women who did not use antidepressant medications, and those who were and were 
not breastfeeding at the postpartum timepoint (Supporting Information Table S3).
Two particular symptom factors exhibited meaningful differences in prevalence between the 
postpartum and after-postpartum timepoints (Figure 1). Pairwise t-tests revealed that 
“Worry” scores were more pronounced during the postpartum timepoint, compared with the 
after-postpartum (t(241)=(1.84,2.63), M of differences=0.04, p=0.03), and “Emotional/
Circadian/Energetic Dysregulation” scores were less pronounced during the postpartum 
timepoint, compared with the after-postpartum (t(241)=(−4.71,−1.26), M of differences=
−0.01, p=0.03). These results were further validated using a different method of analysis. 
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Mixed-effects models supported our calculation that “Worry” scores were more pronounced 
during the postpartum timepoint (β=0.03, p=0.08), and “Emotional/Circadian/Energetic 
Dysregulation” scores were less pronounced during the postpartum timepoint (β=−0.03, 
p=0.04) (Supporting Information Table S2).
Among the subset of women who met traditional research study criteria for at least minor 
depression at the postpartum timepoint, “Worry” and “Emotional/Circadian/Energetic 
Dysregulation” scores differed meaningfully between the two timepoints. Pairwise t-tests 
confirmed that “Worry” scores were more pronounced during the postpartum timepoint, 
compared with the after-postpartum (t(85)=(3.44,4.36), p<0.00). “Emotional/Circadian/
Energetic Dysregulation” scores exhibited no significant difference between the two 
timepoints. It should be noted that subsetting the cohort based on traditional research criteria 
cutoff for minor depression is redundant with “Emotional/Circadian/Energetic 
Dysregulation” scores (logistic regression χ2=20.1, p<0.00, Nagelkerke’s R2=0.7), so 
differences between timepoints would not be expected.
4. DISCUSSION
Depression symptom profiles are known to vary between individuals, as well as within 
individuals over time (Oquendo et al., 2004). Here, we address the question of whether 
depression occurring during the postpartum phase is characterized by a unique symptom 
profile, compared with depression outside the postpartum phase. In a longitudinal cohort of 
239 women assessed at postpartum (3-months after parturition) and after-postpartum (24-
months after parturition) timepoints, we conducted exploratory factor analyses of individual 
symptoms to investigate whether particular symptoms are more likely to present together, 
confirmatory factor analysis and longitudinal invariance modelling (Meredith, 1993; 
Vandenberg & Lance, 2000) to investigate whether the segregation of these symptoms 
differs between the two timepoints, and t-tests to investigate whether symptom cluster 
prevalence varies between timepoints. Results suggest that the structure of symptom profiles 
is not different between the postpartum and after-postpartum timepoints, but the prevalence 
of two particular symptom clusters differs. “Worry” is more pronounced during the 
postpartum, and “Emotional/Circadian/Energetic Dysregulation” is less pronounced during 
the postpartum. Our observation that PPD may have a symptomatic signature that is distinct 
from depression during other life phases is consistent with the possibility that depression 
occurring during the perinatal phase of life is a condition separate from MDD, or a condition 
with unique characteristics.
We found that the Worry symptom cluster was the most pronounced at the postpartum 
timepoint (Figure 1), and was a hallmark differentiating depression profiles at the 
postpartum compared with the after-postpartum timepoint. These results were validated (and 
even stronger) among the subset of women who met traditional research criteria for at least 
minor depression. The Worry symptom cluster comprises anxiety and guilt. While previous 
studies have not assessed symptomology using multiple instruments, previous studies have 
recognized anxiety as a distinctive feature of PPD (Stephen Matthey, Barnett, Howie, & 
Kavanagh, 2003), with multiple reports that postpartum depressed women exhibit enhanced 
anxiety symptoms (C. T. Beck & Indman, 2005; Hendrick et al., 2000). Two studies 
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conducting principal components analysis with the EPDS have found that the three anxiety-
related items comprise a distinct subscale (Brouwers, van Baar, & Pop, 2001; L. Ross, S. G. 
Evans, E. Sellers, & M. Romach, 2003). Furthermore, the 3-item EPDS anxiety subscale 
exhibits strong validity as a predictor of overall EPDS score (Kabir, Sheeder, & Kelly, 2008). 
A cross-sectional study comparing pregnant and postpartum women using anxiety, 
depressed mood, and anhedonia EPDS sub-scales (Stephen Matthey, Fisher, & Rowe, 2013; 
L. E. Ross, S. G. Evans, E. Sellers, & M. Romach, 2003; Tuohy & McVey, 2008) found that 
anxiety and anhedonia were more likely to have postpartum rather than antepartum onset 
(Putnam et al., 2017). Another cross-sectional study found enhanced worthlessness/guilt in 
pregnant compared with non-peripartum women (Hoertel et al., 2015).
We found that prevalence of “Emotional/Circadian/Energetic Dysregulation,” the symptom 
factor that contains sadness, anhedonia, and psychomotor retardation among other 
symptoms, was significantly lower during the postpartum compared with the after-
postpartum timepoint (Figure 1). In other words, women exhibited less emotional/circadian/
energetic dysregulation, during the postpartum compared with the after-postpartum 
timepoint. One previous study observed among postpartum women the sadness symptom 
exhibited significantly weaker correlation with overall depression than it did among non-
postpartum women (Bernstein et al., 2008). Further, the only previous study known to us 
comparing postpartum and non-postpartum depression symptomology documented that 
psychomotor symptoms were relatively reduced among the postpartum cohort, and that this 
was true for women both with and without a clinical diagnosis of depression (Hoertel et al., 
2015). These findings parallel our observation that the factor containing psychomotor 
retardation was reduced during the postpartum in women who did and did not meet the 
threshold for minor depression.
As expected, among the subset of women who met traditional research criteria for at least 
minor depression, no differences in prevalence of “Emotional/Circadian/Energetic 
Dysregulation” between the timepoints were revealed. Traditional research instruments for 
assessment of depression rely heavily on symptoms contained in this factor, so “Emotional/
Circadian/Energetic Dysregulation” scores statistically behave as a close surrogate for the 
cutoff criterion itself.
Given the principal role of sadness/anhedonia in diagnostic determination of MDD 
(American_Psychiatric_Association, 2003), our observation that a distinguishing feature of 
depression during the postpartum phase is lower prevalence of emotional/circadian/energetic 
dysregulation supports the case for different diagnostic criteria to identify MDD and PPD. 
For example, the DSM-5 requires either depressed mood or loss of interest to contribute 
towards five or more symptoms to diagnose MDD (American_Psychiatric_Association, 
2003). If Worry is, instead, the most pronounced feature of PPD, then it could be efficacious 
to consider diagnostic criteria for PPD that emphasize Worry symptoms, rather than 
necessitating presence of depressed mood or loss of interest.
Despite the theoretical supposition from evolutionary anthropology that social signals of 
distress might be a key feature of PPD (Hagen, 1999), we observed no overrepresentation of 
“Distress Display” (the symptom factor that includes crying, sad affect display, and thoughts 
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of self-harm) in our data. We found no significant differences in prevalence of this factor 
between the postpartum and after-postpartum timepoints (Figure 1). Previous authors have 
described similar observations in this regard. One study of PPD symptomology found that 
the symptoms with the five lowest prevalence scores were all related to suicidal thoughts (C. 
T. Beck & Indman, 2005), another found that postpartum women exhibited less suicidal 
thoughts than non-postpartum women (Bernstein et al., 2008), and another observed less 
suicidality in postpartum compared with non-peripartum women (Hoertel et al., 2015). 
Future evolutionary frameworks for understanding the potential function or selective 
consequences of PPD should consider the symptom profiles that characterize the condition.
Determining whether PPD is a distinct syndrome from MDD has important implications for 
public health surveillance as well as designing and assessing prevention strategies and 
treatment practices. Hendrick et al. found differences in treatment efficacy for depression 
among postpartum compared with non-postpartum women (Hendrick et al., 2000). 
Postpartum women exhibited longer time to response for pharmacological treatment, and 
greater need to be on two or more antidepressant agents to achieve response. Beck and 
Indman suggest that “[c]linicians need to be cognizant of the fact that anxiety and not 
depression may be the presenting symptom of mothers suffering from postpartum 
depression” (C. T. Beck & Indman, 2005). In this vein, an important question for future 
research will be to determine how anxiety in the postpartum period may differ from that 
characterizing generalized anxiety disorder or anxiety manifesting outside of the peripartum 
period.
A major strength of this investigation is the longitudinal study design and the broad 
characterization of depressive symptoms, which allows us to observe each postpartum 
woman compared to herself during a later life-phase. This life-course, trajectory approach to 
investigating depressive symptomology is unprejudiced by bias or random differences 
between cohorts. A limitation of the study is that we are not able to compare these results to 
a non-perinatal cohort. However, we were able to ensure no pregnancies or miscarriages over 
a two-year period in an adult female cohort, which would pose logistical challenges if a 
cross-sectional comparison cohort were sought. Another limitation is the latest after-
postpartum timepoint we were able to assess in this study is two-years-post-parturition, and 
future studies are needed to confirm that two years is sufficiently representative of 
depressive symptoms not associated with perinatal experiences. Future studies with a larger 
sample size of individuals followed across a longer time scale are needed to validate our 
findings.
5. CONCLUSION
Our results suggest that PPD has a symptomatic signature involving greater prevalence of 
Worry and lower prevalence of Emotional/Circadian/Energetic Dysregulation. This 
observation is consistent with the possibility that PPD represents a unique syndrome from 
MDD occurring outside the perinatal phase. Future studies should compare psychobiological 
mechanisms of symptom manifestation in PPD and MDD to further investigate the validity 
of these diagnostic categories.
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Figure 1. 
Differences in symptom cluster prevalences between the postpartum and after-postpartum 
timepoints. Results suggest that the “Worry” factor is more prevalent during the postpartum 
compared with the after-postpartum timepoint, and the “Emotional/Circadian/Energetic 
Dysregulation” factor is less pronounced during the postpartum compared with the after-
postpartum timepoint. Pooled Pearson product-moment correlations between timepoints: 
factor 1 r=0.49, p<0.00***; factor 2 r=0.27; p=0.01**; factor 3 r=0.24, p=0.01*; factor 4 
r=0.48, p<0.00***; factor 5 r=0.62, p<0.00***; factor 6 r=0.12, p=0.11.
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Table 3
Factor structure from exploratory factor analysis of postpartum depression symptoms
Factor Item Loading on factor
Factor 1, “Worry” Anxiety 1.000
Guilt 0.418
Factor 2, “Anger” Anger attacks 0.906
Anger 0.458
Factor 3, “Emotional/Circadian/Energetic Dysregulation” Agitated 0.635
Irritability 0.551
Anhedonia 0.515
Fatigue 0.497
Sad 0.471
Inability to stay asleep 0.304
Psychomotor retardation 0.300
Factor 4, “Appetite” Low appetite 1.000
Factor 5, “Somatic/Cognitive” GI problems 0.718
Pain 0.597
Inability to focus 0.427
Palpitations 0.378
Factor 6, “Distress display” Sad affect display 0.601
Crying 0.540
Thoughts of self harm 0.421
none Negative reactivity none
none Pessimism none
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